EyePoint Pharmaceuticals Files Lawsuit Against Ocular Therapeutix Over Drug Claims

EyePoint Pharmaceuticals has initiated a lawsuit against Ocular Therapeutix, asserting that false claims were made regarding their eye drug. The outcome of this legal battle could influence public perception and trust in both companies' products within the ophthalmic drug market. Legal proceedings in the pharmaceutical sector can have implications for market positioning and share prices. As of now, there are no specified financial figures or impacts on trading volumes related to this lawsuit.